LSE:GNS 수익, 비용 및 수입 (GBP Millions )
날짜	수익	수익	G+A 비용	R&D 비용
31 Dec 23	673	33	101	93
30 Sep 23	681	33	100	93
30 Jun 23	690	33	99	93
31 Mar 23	676	34	94	83
31 Dec 22	662	34	90	73
30 Sep 22	628	38	89	73
30 Jun 22	593	41	89	73
31 Mar 22	582	39	92	71
31 Dec 21	570	37	95	68
30 Sep 21	572	42	96	68
30 Jun 21	574	47	97	68
31 Mar 21	570	45	93	70
31 Dec 20	566	42	89	71
30 Sep 20	559	39	89	71
30 Jun 20	551	35	88	71
31 Mar 20	536	37	80	66
31 Dec 19	520	39	72	61
30 Sep 19	504	23	72	61
30 Jun 19	489	8	72	61
31 Mar 19	480	1	76	56
31 Dec 18	471	-7	81	51
30 Sep 18	470	18	81	51
30 Jun 18	470	43	82	51
31 Mar 18	473	55	80	48
31 Dec 17	476	67	79	45
30 Sep 17	467	50	79	45
30 Jun 17	459	33	78	45
31 Mar 17	441	40	75	40
31 Dec 16	422	47	71	34
30 Sep 16	405	48	71	34
30 Jun 16	388	49	71	34
31 Mar 16	388	40	68	32
31 Dec 15	388	31	64	29
30 Sep 15	393	35	64	29
30 Jun 15	399	40	64	29
31 Mar 15	394	36	60	28
31 Dec 14	389	32	56	28
30 Sep 14	381	30	57	28
30 Jun 14	372	29	58	28
31 Mar 14	366	27	59	28
31 Dec 13	360	25	60	28
30 Sep 13	353	24	60	28

양질의 수익: GNS 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: GNS 의 현재 순이익 이익률 (5%) 작년보다 낮습니다 (5.2%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: GNS 지난 5년 동안 수익을 창출하여 매년 15.3% 수익을 올렸습니다.

성장 가속화: GNS 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: GNS 은 지난 1년 동안 마이너스 수익 성장( -2.9% )을 기록하여 Biotechs 업계 평균( 3% ).

Genus 과거 수익 실적

과거 기준 확인 2/6

주요 정보

최근 과거 실적 업데이트

First half 2024 earnings released: EPS: UK£0.21 (vs UK£0.20 in 1H 2023)

Genus plc to Report Fiscal Year 2024 Results on Sep 05, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Full year 2023 earnings: EPS exceeds analyst expectations

First half 2023 earnings released: EPS: UK£0.20 (vs UK£0.30 in 1H 2022)

Genus plc to Report Fiscal Year 2023 Results on Sep 07, 2023

Recent updates

The Price Is Right For Genus plc (LON:GNS)

Price target decreased by 7.9% to UK£28.74

Estimating The Fair Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) Using Too Much Debt?

With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Investor sentiment deteriorates as stock falls 15%

Price target decreased by 10% to UK£29.62

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103

First half dividend of UK£0.10 announced

First half 2024 earnings released: EPS: UK£0.21 (vs UK£0.20 in 1H 2023)

Consensus EPS estimates fall by 23%

Investor sentiment deteriorates as stock falls 19%

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult

Genus Appoints Ralph Heuser as Non-Executive Director, with effect from 1 January 2024

Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?

Genus plc to Report Fiscal Year 2024 Results on Sep 05, 2024

Genus plc Approves to Declare Final Dividend

We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt

Upcoming dividend of UK£0.22 per share at 1.4% yield

Full year 2023 earnings: EPS exceeds analyst expectations

Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs

Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs

Executive Director exercised options and sold UK£194k worth of stock

Consensus EPS estimates fall by 19%

Calculating The Intrinsic Value Of Genus plc (LON:GNS)

Full year 2023 earnings: EPS exceeds analyst expectations

Genus plc Announces Lykele Van Der Broek to Step Down from the Genus Board

AB Agri Ltd. completed the acquisition of National Milk Records plc (OFEX:NMRP) from Livestock Improvement Corporation Limited (NZSE:LIC), ICM Investment Management Limited, Genus plc (LSE:GNS), Custodial Capital Management Limited, High Street Partners, Ltd, and Working Capital Partners Ltd.

Price target decreased by 8.4% to UK£38.82

Now 20% undervalued after recent price drop

Price target decreased by 8.0% to UK£40.28

Is Genus (LON:GNS) A Risky Investment?

First half 2023 earnings released: EPS: UK£0.20 (vs UK£0.30 in 1H 2022)

Is Genus (LON:GNS) Using Too Much Debt?

Price target decreased to UK£40.14

Genus plc to Report Fiscal Year 2023 Results on Sep 07, 2023

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Investor sentiment improved over the past week

Upcoming dividend of UK£0.22 per share

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Genus' (LON:GNS) Dividend Will Be £0.217

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

A Look At The Fair Value Of Genus plc (LON:GNS)

Investor sentiment improved over the past week

Genus plc Proposes Final Dividend, Payable on 9 December 2022

Investor sentiment improved over the past week

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

Price target decreased to UK£46.05

Is Genus (LON:GNS) A Risky Investment?

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Genus plc Proposes Interim Dividend, Payable on March 31, 2022

Genus plc to Report First Half, 2022 Results on Feb 24, 2022

Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Independent Non-Executive Chairman recently bought UK£224k worth of stock

Upcoming dividend of UK£0.22 per share

With EPS Growth And More, Genus (LON:GNS) Is Interesting

Full year 2021 earnings released: EPS UK£0.73 (vs UK£0.54 in FY 2020)

Chief Operating Officer recently sold UK£336k worth of stock

Here's Why Genus (LON:GNS) Can Manage Its Debt Responsibly

Insider recently sold UK£1.4m worth of stock

Full year 2021 earnings released: EPS UK£0.73 (vs UK£0.62 in FY 2020)

Genus plc (LSE:GNS) acquired Trade and assets of Sergal Gestio Ramadera, S.L. from Sergal Gestio Ramadera Sl for £7.7 million.

Independent Non-Executive Director Ian Charles has left the company

Genus (LON:GNS) Could Easily Take On More Debt

Independent Non-Executive Chairman recently bought UK£72k worth of stock